SI-BONE delivered a robust second quarter in 2025, with worldwide revenue increasing by 21.7% to $48.6 million. The company achieved positive Adjusted EBITDA of $1.0 million and generated $1.1 million in net cash, demonstrating strong operational performance and disciplined execution. Net loss improved by 31.2% to $6.2 million.
Worldwide revenue grew by 21.7% to $48.6 million, driven by strong U.S. performance.
Achieved positive Adjusted EBITDA of $1.0 million, a significant improvement from a loss in the prior year.
Generated $1.1 million in net cash during the quarter, reaching cash flow breakeven.
Net loss improved by 31.2% to $6.2 million, or $0.14 per diluted share.
SI-BONE raised its full-year 2025 financial guidance, expecting worldwide revenue between $195 million and $198 million, implying 17% to 18% year-over-year growth. The company anticipates gross margin between 78.5% and 79.0% and expects to deliver positive adjusted EBITDA for the full year.
Visualization of income flow from segment revenue to net income